IDD-Xpert

What IDD-Xpert does

IDD-Xpert is a French contract research organization (CRO) and pharmaceutical R&D platform headquartered in Évreux, France, specializing in the life cycle management of pharmaceutical products, new chemical entities, and biotech products. Founded in 2012 with 11-50 employees, the company operates an integrated platform spanning preformulation through pilot-scale GMP manufacturing for oral and inhaled pharmaceutical forms. Its core technical capabilities include physical characterization of powders and mixtures (XRPD, DSC, DVS, TGA-IR, BET, laser granulometry), formulation development using DOE/QbD approaches, GMP manufacturing of respiratory forms (pMDI with HFA propellants, DPI), solid dosage forms (tablets, capsules), and cytotoxic/sterile forms using single-use isolators under Class A/B environments.

The company holds ANSM approval for clinical and commercial QC operations and is pursuing additional authorization for cytotoxic and sterile forms GMP manufacturing. Its specialized testing capabilities include aerodynamic particle size distribution (ACI-NGI), dose uniformity for inhaled products, and plaster/transdermal testing (tension, tear, peel, probe tack, drug release). Beyond manufacturing, IDD-Xpert provides analytical method development and validation, forced degradation studies, extractables/leachables studies, stability testing at all ICH conditions, and regulatory consulting — positioning it as a one-stop development partner for pharmaceutical and biotech clients, including innovative startups.

The business model is built on professional services revenue through customized contracts with pharmaceutical and biotech companies. The company serves 300+ international customers via direct enterprise sales engagement. Revenue streams include contract R&D services (preformulation, formulation, analytical development, stability, regulatory consulting), clinical batch manufacturing and release, and technology transfer services including manufacturing scale-up/down and process validation. Pricing is quote-based and not publicly disclosed. The company maintains a global operating footprint with a GMP manufacturing facility in France, targeting enterprises and innovative startups requiring specialized pharmaceutical development capabilities. Recent strategic initiatives include a 2025 partnership with InBrain Pharma to scale up anaerobic dopamine production for Parkinson's disease therapeutics.

Name

IDD-Xpert

Legal name

IDD-Xpert

Website

https://idd-xpert.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

IDD-Xpert is a French GMP-certified pharmaceutical CRO providing integrated R&D, manufacturing, and analytical services for respiratory forms (pMDI, DPI), solid dosage forms, and cytotoxic/sterile products, serving 300+ pharmaceutical and biotech clients globally from its Évreux facility.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Research & Manufacturing Services (CRO/CDMO)

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL)

akta.pro secondary industries

Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control) (HLAGAKAL), Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)

Keywords

• Pharmaceutical development services
• Contract research organization
• GMP manufacturing services
• Analytical testing services
• Respiratory drug delivery

Headquarters

HQ city

Évreux

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Contract R&D Services: Preformulation and formulation studies, analytical method development and validation, stability studies, and regulatory consulting services for pharmaceutical development.
2. Clinical Batch Manufacturing: Manufacturing and release of clinical and pilot batches for oral and inhaled pharmaceutical forms under GMP conditions.
3. Technology Transfer Services: Industrial transfer services including scale-up and scale-down of manufacturing processes, trouble-shooting, and manufacturing process validation.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

IDD-Xpert is an R&D platform and Contract Research Organization (CRO) for the life cycle management of pharmaceutical products, new chemical entities, and biotech products. The company handles preformulation and formulation studies from API to drug product, GMP manufacturing and release of clinical and pilot batches for oral and inhaled forms, with capabilities spanning lab scale to pilot scale including physical characterization, formulation using DOE/QbD, manufacturing scale-up/down, analytical method development, QC, and stability studies. Services are delivered from a GMP manufacturing facility in Évreux, France, serving over 300 international pharmaceutical and biotech customers.

Product overview

IDD-Xpert operates as an integrated R&D platform and CRO (Contract Research Organization) offering comprehensive pharmaceutical development services from preformulation through pilot-scale manufacturing. The portfolio encompasses five interconnected service/product lines: (1) an R&D Platform providing core formulation development and technology transfer, (2) Powder Characterisation services for physical/chemical analysis, (3) Manufacturing capabilities for respiratory forms (pMDI/DPI), solid dosage forms (tablets/capsules), and cytotoxic/sterile products, (4) Analytical Services covering QC testing and stability studies, and (5) Specific QC Expertise including pharmacotechnical analyses and extractables/leachables studies. The company serves over 300 international customers with GMP-compliant operations located in Evreux, France.

Differentiator

Problem solved

Functional benefit

Products and services

• R&D Platform & CRO Services Full-service pharmaceutical R&D platform for life cycle management of pharmaceutical, new chemical, and biotech products, handling preformulation and formulation studies from API to drug product, GMP manufacturing, release of clinical and pilot batches for oral and inhaled forms, plus consulting and regulatory support.
• Powder Characterisation Physical and chemical characterization of powders and mixtures including XRPD/DSC for solid state, crystallinity, polymorphism, and amorphous content; DVS for hygroscopicity and hydrate/solvate studies; TGA-IR for water/solvent content; BET for specific surface area; Spraytec/laser granulometry for particle size distribution; and optical microscopy for shape and surface characteristics.
• GMP Manufacturing Services GMP manufacturing services for respiratory forms (pMDI, DPI), solid dosage forms (tablets, capsules), and cytotoxic/sterile products, with scale-up/down capabilities from laboratory to pilot scale and dedicated manufacturing areas.
• Analytical Services ANSM-approved complete analytical platform for clinical and commercial QC, including analytical method development, validation and transfer, forced degradation studies, extractables/leachables studies, stability testing at all ICH conditions, and chromatography using HPLC, UPLC, UV, and DAD.
• Respiratory Forms (pMDI/DPI) Pressurized Metered Dose Inhaler (pMDI) and Dry Powder Inhaler (DPI) development and manufacturing with HFA propellant evaluation (HFA134a, HFA227, HFA152a), valve/can/API supplier evaluation, and GMP scale-up capabilities including 20L and 100L vessels.
• Solid Dosage Forms Tablet and capsule manufacturing including instrumented Stylcam formulation support, wet granulation with fluid bed drying, tablet coating, and GMP scale-up for clinical batches up to 15,000 tablets.
• Cytotoxic and Sterile Forms Manufacturing Dedicated GMP manufacturing area for cytotoxic and sterile forms with single-use isolators under Class A/B environment, freeze dryer equipment for small batches (1,000 vials), and an ongoing ANSM authorization request for GMP batch release.
• Specific QC Expertise Pharmacotechnical analyses for oral forms (disintegration, hardness, dissolution, friability), inhaled product testing (aerodynamic particle size distribution via ACI-NGI, intra/inter-device dose uniformity, spray pattern, plume geometry, pressure drop), plaster/transdermal testing (tension, tear, peel, probe tack, sealing, absorption, flexibility, drug release by HPLC/GC), and extractables/leachables studies.

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• InBrain PharmacoreStrategic or Co-development Partner · 12 May 2025IDD-Xpert partnered with InBrain Pharma to scale up manufacturing processes for anaerobic dopamine production. This partnership supports InBrain Pharma's €1.8 million funding from France's 'First Factory' initiative for industrializing dopamine production targeting Parkinson's disease. IDD-Xpert's role focuses on manufacturing scale-up to meet clinical and commercial needs.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Direct peers

• Hovione: Hovione is a Portugal-based CDMO with deep specialization in inhaled drug development (pMDI and DPI) and particle engineering, plus broader small-molecule API and formulation services. It is the closest functional peer to IDD-Xpert's inhalation and preformulation offering, operating at significantly larger scale.
• Aptar Pharma: Aptar Pharma is a leading developer and manufacturer of inhalation drug delivery devices (pMDI valves, DPI components) and offers associated development services. It is highly comparable to IDD-Xpert's respiratory forms business, particularly around device-component selection and inhalation development support.

Broad incumbents

• Catalent: Catalent is a large global CDMO with extensive oral solid, inhalation, and sterile manufacturing capabilities, plus softgel and biologics services. It competes with IDD-Xpert across multiple service lines but at a much broader portfolio scale, serving as the benchmark large incumbent in the same procurement decisions.
• Delpharm: Delpharm is a France-headquartered CDMO providing contract manufacturing of solid, liquid, sterile, and inhaled pharmaceutical forms for European sponsors. It shares IDD-Xpert's French base and serves overlapping GMP contract manufacturing demand at a larger scale.
• Cambrex: Cambrex is a US- and Europe-based CDMO offering small-molecule API development, solid dose manufacturing, and analytical services. It is comparable to IDD-Xpert in offering analytical method development and clinical supply manufacturing for pharmaceutical clients, though at substantially greater scale.
• Eurofins CDMO: Eurofins' CDMO arm (formerly Amatsigroup) provides drug product development, clinical and commercial GMP manufacturing, and analytical services across Europe. It is a comparable European mid-tier CDMO serving similar biotech and pharma clients as IDD-Xpert.
• Pharmaron: Pharmaron is a global CRO/CDMO offering drug discovery, formulation development, analytical services, and GMP manufacturing across small molecules and biologics. It overlaps with IDD-Xpert's preformulation, analytical, and clinical-batch manufacturing services at much larger scale.
• Aenova: Aenova is a European CDMO offering solid, semi-solid, sterile, and liquid dose manufacturing plus development services. It competes with IDD-Xpert's solid dosage and GMP manufacturing services for European pharmaceutical clients.
• Recipharm: Recipharm is a European CDMO offering solid dose, semi-solids, sterile, and inhalation manufacturing services. Its broad service portfolio and European footprint overlap directly with IDD-Xpert's GMP manufacturing and analytical services offerings for pharmaceutical clients.

Emerging players

• Upperton Pharma Solutions: Upperton is a UK-based contract development and clinical manufacturing organization specializing in oral and inhaled dosage forms, including spray drying and DPI development. It is a close peer in scale and service mix, targeting similar early-stage pharma and biotech clients.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/idd-expert
• Facebookfacebook.com/profile.php

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IDD-Xpert